Clinical trial • Phase I • Neurology
RO7568282 for Parkinson's disease
Phase I trial of RO7568282 for Parkinson's disease. 140 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Parkinson's disease
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 03-07-2024
- First CTIS Authorization Date
- 27-08-2024
Trial design
Phase I trial across 5 sites in Netherlands.
- Target Sample Size
- 140
Eligibility
Recruits 140 Vulnerable population selected; no details on consent or assent provided..
- Vulnerable Population
- Vulnerable population selected; no details on consent or assent provided.
Recruitment
- Planned Sample Size
- 140
- Recruitment Window Months
- 42
Geography
- Total Number Of Sites
- 5
- Total Number Of Participants
- 140
Netherlands
- Earliest CTIS Part Ii Submission Date
- 12-08-2024
- Latest Decision Or Authorization Date
- 16-09-2025
- Processing Time Days
- 400
- Number Of Sites
- 5
- Number Of Participants
- 140
Sites
- Site Name
- Radboud universitair medisch centrum Stichting
- Principal Investigator Name
- Bas Bloem
- Principal Investigator Email
- bas.bloem@radboudumc.nl
- Contact Person Name
- Bas Bloem
- Contact Person Email
- bas.bloem@radboudumc.nl
- Site Name
- Pharmaceutical Research Associates Group B.V.
- Department Name
- Program Management
- Principal Investigator Name
- Jart Oosterhaven
- Principal Investigator Email
- Jart.Oosterhaven@iconplc.com
- Contact Person Name
- Jart Oosterhaven
- Contact Person Email
- Jart.Oosterhaven@iconplc.com
- Site Name
- Brain Research Center Zwolle B.V.
- Principal Investigator Name
- Teus Van Laar
- Principal Investigator Email
- t.van.laar@umcg.nl
- Contact Person Name
- Teus Van Laar
- Contact Person Email
- t.van.laar@umcg.nl
- Site Name
- Brain Research Center Amsterdam B.V.
- Principal Investigator Name
- Everart Jort Vijverberg
- Principal Investigator Email
- j.vijverberg@brainresearchcenter.nl
- Contact Person Name
- Everart Jort Vijverberg
- Contact Person Email
- j.vijverberg@brainresearchcenter.nl
- Site Name
- Brain Research Center Den Bosch B.V.
- Principal Investigator Name
- Gerwin Roks
- Principal Investigator Email
- g.roks@etz.nl
- Contact Person Name
- Gerwin Roks
- Contact Person Email
- g.roks@etz.nl
Sponsor
Primary sponsor
- Full Name
- F. Hoffmann-La Roche AG
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Switzerland
Investigational products
- Investigational Product Name
- RO7568282
Related trials
Other published trials that may interest you.